Quantcast
Last updated on April 17, 2014 at 11:11 EDT

Latest IMRIS Inc. Stories

2013-05-01 16:29:42

Three internationally prominent surgeons to consult on neurosurgical robot commercialization WINNIPEG, May 1, 2013 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced the establishment of the SYMBIS(TM) Surgical System Advisory Board, comprised of three internationally recognized surgeons in the fields of neurosurgery and robotics. The advisory board will provide guidance in the development, clinical study, training and commercialization of...

2013-04-30 12:27:55

WINNIPEG, April 30, 2013 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ____________________________________________________________________ |First Quarter 2013 Earnings Release|May 2, 2013 | |___________________________________|________________________________| |Conference Call and Webcast |May 2, 2013 5:00 pm ET | |___________________________________|________________________________| |Hosted by...

2013-04-22 12:31:18

Learn more about IMRIS neurosurgical imaging products at booth #2013 WINNIPEG, April 22, 2013 /PRNewswire/ - IMRIS, Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that it will exhibit its novel intraoperative CT solution with state-of-the-art imaging that is currently under development at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting, April 27-May 1, in New Orleans, LA. Attendees are invited to visit the IMRIS booth...

2013-03-18 12:28:40

WINNIPEG, March 18, 2013 /PRNewswire/ - IMRIS Inc. ("IMRIS" or the "Company") (NASDAQ: IMRS; TSX: IM) today announced that it has closed its underwritten public offering of 5,750,000 common shares at a public offering price of US$3.50 per share. The gross proceeds to IMRIS, before underwriting commissions and other offering expenses, were approximately US$20.1 million. Canaccord Genuity acted as sole book-running manager for the offering and Cowen and Company, LLC acted as...

2013-03-12 16:24:12

WINNIPEG, March 12, 2013 /PRNewswire/ - IMRIS Inc. ("IMRIS" or the "Company") (NASDAQ: IMRS; TSX: IM) today announced that it has commenced an underwritten public offering of its common shares.  The offering is being conducted in the United States pursuant to the Company's effective shelf registration statement filed with the U.S. Securities and Exchange Commission (the "SEC") and in Canada pursuant to a final short form base shelf prospectus filed with the securities regulatory...

2013-03-05 16:26:00

In TO307 transmitted at 16:05e, an error occurred in the links to the PDFs at the end of the press release. Links to IMRIS' PDFs have been corrected to include Fourth Quarter MD&A and Financial Statements. Corrected copy follows: IMRIS reports fourth quarter and annual 2012 financial results WINNIPEG, March 5, 2013 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today reported its results for the fourth quarter and full year of 2012.  All...

2013-03-05 16:25:47

WINNIPEG, March 5, 2013 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today reported its results for the fourth quarter and full year of 2012.  All figures are reported in US dollars. Highlights: -- Fourth quarter order bookings of $24 million contribute to record full year 2012 orders of $89 million -- Backlog increases 29% in 2012 to $123 million at December 31, 2012 -- Quarterly revenues of...

2013-02-27 12:27:14

WINNIPEG, Feb. 27, 2013 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ____________________________________________________________________ |Q4 and Annual 2012 Earnings Release|March 5, 2013 | |___________________________________|________________________________| |Conference Call and Webcast |March 5, 2013 5:00 pm ET | |___________________________________|________________________________| |Hosted by...

2013-02-13 12:27:32

Physicians can confirm if all of tumor is resected without moving patient WINNIPEG, Feb. 13, 2013 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced neurosurgeons at University of Tsukuba Hospital in Ibaraki, Japan, have performed initial tumor removal cases using its VISIUS(®) Surgical Theatre. The intraoperative MRI system is the only one of its kind in Japan that allows for high quality image scanning during an operation without...

2013-02-07 12:28:18

Brings cutting edge surgery and precise tumor operation platform to patient care WINNIPEG, Feb. 7, 2013 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that neurosurgeons at the First Affiliated Hospital of Zhengzhou University in Zhengzhou City, China, have successfully performed the first case involving an adult male brain tumor patient using the recently installed VISIUS(®) Surgical Theatre. Allowing for multiple MR scanning...